Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library

Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety - Duszynski - 2021 - Pharmacoepidemiology and Drug Safety - Wiley Online Library

Active Vaccine Safety Surveillance: Global Trends and Challenges in China

Severe Guillain-Barré Syndrome Following Shingrix® Vacc

Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy) - ScienceDirect

Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines

Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study - The Lancet Regional Health – Western Pacific

A distributed research network model for post-marketing safety studies: The Meningococcal Vaccine Study

PDF) Guillain-Barré Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA

Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review - Franco - 2020 - Pharmacology Research & Perspectives - Wiley Online Library

Pharmacoepidemiology [6th Edition] 9781119413370

Frontiers Intensive Care and Treatment of Severe Guillain–Barré Syndrome

Real-world treatment of adult patients with Guillain-Barré syndrome over the last two decades

Guillain-Barré syndrome after exposure to influenza virus - The Lancet Infectious Diseases

BioMed, Free Full-Text